Life Science & Biotech Companies in Greater London

Gene editing platform restoring disease resistance in crop species

Resurrect Bio is a plant biotechnology company developing disease-resistant crops through a proprietary gene editing platform. Using computational biology and high-throughput plant screening, the company identifies and restores native resistance genes that have been suppressed by pathogens or lost through selective…

AI-designed combination therapies for cancer

Big Picture Bio is a preclinical biotechnology company designing combination therapies for cancer. Its generative model simulates how tumours, immune cells and surrounding tissue interact, and is used to predict which drug combinations, and which sequences of treatment, are most likely to suppress resistant cancer…

Global specialist pharmaceutical company focused on HIV

ViiV Healthcare is a specialist pharmaceutical company dedicated to the research, development, and commercialisation of medicines for HIV treatment and prevention. Its portfolio includes widely used antiretroviral therapies such as Dovato and the long-acting injectable Cabenuva, and it is advancing next-generation…

AI platform for drug target identification and discovery

BenevolentAI is a UK-founded biotech company that develops and applies AI and machine learning to accelerate drug discovery. Its platform integrates knowledge graphs, proprietary ontologies, and large language models to identify novel therapeutic targets and design small molecule candidates across multiple disease…

Quantum-informed computational design of covalent drug candidates

Axiom Therapeutics is a London biotechnology company using molecular physics and machine learning to design covalent small-molecule medicines. Its computational drug-discovery platform models interactions between reactive compounds and biological targets, helping design selective inhibitors for difficult-to-drug…

Bacterial nanocellulose biomaterials replacing leather and plastic-coated textiles

Modern Synthesis develops biomaterials using nanocellulose produced through bacterial fermentation. The company combines the natural fibres with biopolymers and textiles to make durable alternatives to animal leather and plastic-coated fabrics. Its processes include roll-to-roll manufacturing designed to work with…

Global commercialisation of specialty, hospital and rare disease medicines

ADVANZ PHARMA is a global pharmaceutical company focused on the commercialisation of specialty, hospital and rare disease medicines, partnering with biopharma and pharmaceutical development companies to bring treatments to patients. The company's portfolio spans therapeutic areas including hepatology,…

Biomedical software development for genomics and medical imaging

Phenopolis is a London scientific software company developing applications and analysis pipelines for biomedical research and healthcare. Its services cover genetics, DNA methylation analysis, medical imaging, large-scale data processing and secure handling of patient information. It builds cloud and on-premises…

Bacillus spore-based vaccines, drug delivery and probiotic therapeutics developer

SporeGen is a biotechnology company working exclusively on spore-forming Bacillus bacteria to develop vaccines, drug delivery platforms and probiotic therapeutics. The company's SporeVax platform uses bacterial spores as a vaccine delivery agent, and its SPOR-COV nasal spray, developed with a commercial partner, aims…

Biologic therapies for autoinflammatory and autoimmune diseases

Kiniksa Pharmaceuticals International is a commercial-stage biopharmaceutical company focused on acquiring, developing and commercialising medicines for autoinflammatory and autoimmune diseases with significant unmet need. Its approved product, rilonacept, is an IL-1 inhibitor indicated for recurrent pericarditis. The…

Patient-controlled DNA biobank platform for precision prescribing insights

GeneHub is a London-based digital health company operating a patient-controlled biobank platform that rewards patients with free DNA tests and insights in exchange for sharing anonymised genetic data with researchers and clinicians. The platform aims to support precision prescribing, helping reduce adverse drug…

End-to-end viral vector design, production and gene delivery

VectorBuilder is a global provider of gene delivery solutions offering an integrated suite of research products, custom services, and clinical-grade manufacturing. The company's platform spans viral vector design and cloning, packaging of lentiviral, AAV, and adenoviral vectors, plasmid and IVT mRNA manufacture,…

Oncolytic vaccinia virus platform targeting refractory solid tumours

VacV Biotherapeutics is a cancer immunotherapy company developing engineered oncolytic Vaccinia virus-based therapeutics for the treatment of solid tumours. Spun out of Barts Cancer Institute and Queen Mary University of London, the company's platform uses a modified Vaccinia virus to simultaneously destroy tumour…

Graph AI platform for crop gene target discovery and precision breeding

Biographica is a London agbiotech developing a graph machine learning platform to identify and validate gene editing targets for crop improvement. The platform integrates genomic, transcriptomic, and scientific literature data within knowledge graphs, combining in silico modelling with in vivo validation at Rothamsted…

Not-for-profit research organisation targeting intrinsically disordered proteins

Bind Research is the UK's first Focused Research Organisation, established to make intrinsically disordered proteins druggable targets for new medicines. The organisation integrates NMR spectroscopy, biophysical characterisation, chemoproteomics, and AI to build comprehensive datasets of disordered protein-small…

AI-powered scientific knowledge management and laboratory workspace

Labbera is a software company developing an AI-enabled workspace for scientific and laboratory research teams. Its platform connects experimental records, spreadsheets, files, meeting notes and project tasks into a searchable body of research context. Users can ask questions about previous experiments, retrieve…

Global cell and gene therapy CDMO

Minaris Advanced Therapies is a company providing contract development, manufacturing and testing services across the cell and gene therapy lifecycle. Its UK operations originate from the former Oxgene business, contributing proprietary AAV and lentiviral manufacturing technologies. In December 2025 the company…

AI-powered molecular design software for medicinal chemists

deepmirror is a software company developing an AI-powered drug design application for medicinal chemists. Its no-code interface integrates generative molecular design with predictive modelling of key drug properties including target affinity, ADMET profiles and solubility, enabling hit-to-lead and lead optimisation…

Contract analytical chemistry and quality control testing for pharmaceutical materials

Butterworth Laboratories is an independent contract analytical chemistry laboratory providing quality control testing, method development and stability testing to the pharmaceutical and related industries. The company tests raw materials, excipients, active pharmaceutical ingredients and finished products against…

Microbiome emulation platform for drug development de-risking

BioCorteX is a biotech company that applies computational emulation to model interactions between drugs, the human microbiome, and the immune system. Its platform uses physics- and chemistry-based simulation to generate in-silico predictions of drug-bacteria interactions across diverse patient populations. The…